Viewing Study NCT01049620


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-05-14 @ 4:32 AM
Study NCT ID: NCT01049620
Status: COMPLETED
Last Update Posted: 2020-01-07
First Post: 2010-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX
Sponsor: Asan Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Gastric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None XELOX View
None RAD001 View
None phase 1 View